89bio, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 28.84 million compared to USD 25.57 million a year ago. Basic loss per share from continuing operations was USD 0.54 compared to USD 1.26 a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.73 USD | -2.15% | -5.89% | -29.90% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.30% | 777M | |
+14.23% | 118B | |
+12.94% | 106B | |
-3.46% | 24.28B | |
+1.14% | 21.96B | |
-9.35% | 18.16B | |
-42.28% | 16.37B | |
-18.01% | 15.56B | |
+4.34% | 13.63B | |
+27.59% | 12.27B |
- Stock Market
- Equities
- ETNB Stock
- News 89bio, Inc.
- 89bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023